1. Home
  2. NSPR vs GRWG Comparison

NSPR vs GRWG Comparison

Compare NSPR & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • GRWG
  • Stock Information
  • Founded
  • NSPR 2005
  • GRWG 2008
  • Country
  • NSPR Israel
  • GRWG United States
  • Employees
  • NSPR N/A
  • GRWG N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • GRWG RETAIL: Building Materials
  • Sector
  • NSPR Health Care
  • GRWG Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • GRWG Nasdaq
  • Market Cap
  • NSPR 75.6M
  • GRWG 82.3M
  • IPO Year
  • NSPR N/A
  • GRWG N/A
  • Fundamental
  • Price
  • NSPR $2.58
  • GRWG $1.05
  • Analyst Decision
  • NSPR Strong Buy
  • GRWG Buy
  • Analyst Count
  • NSPR 2
  • GRWG 4
  • Target Price
  • NSPR $4.75
  • GRWG $2.75
  • AVG Volume (30 Days)
  • NSPR 67.4K
  • GRWG 749.8K
  • Earning Date
  • NSPR 03-12-2025
  • GRWG 03-13-2025
  • Dividend Yield
  • NSPR N/A
  • GRWG N/A
  • EPS Growth
  • NSPR N/A
  • GRWG N/A
  • EPS
  • NSPR N/A
  • GRWG N/A
  • Revenue
  • NSPR $7,009,000.00
  • GRWG $188,866,000.00
  • Revenue This Year
  • NSPR $50.18
  • GRWG $0.59
  • Revenue Next Year
  • NSPR $159.56
  • GRWG N/A
  • P/E Ratio
  • NSPR N/A
  • GRWG N/A
  • Revenue Growth
  • NSPR 12.96
  • GRWG N/A
  • 52 Week Low
  • NSPR $1.81
  • GRWG $0.91
  • 52 Week High
  • NSPR $3.80
  • GRWG $3.38
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 39.79
  • GRWG 38.88
  • Support Level
  • NSPR $2.57
  • GRWG $1.11
  • Resistance Level
  • NSPR $2.78
  • GRWG $1.30
  • Average True Range (ATR)
  • NSPR 0.16
  • GRWG 0.10
  • MACD
  • NSPR -0.01
  • GRWG 0.00
  • Stochastic Oscillator
  • NSPR 31.82
  • GRWG 39.74

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

Share on Social Networks: